GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Resapp Health RAP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.02

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

—

FY2016FY2026

Net income

−A$3.3m

FY2016FY2026

Free cash flow

—

FY2016FY2026

Shareholders' equity

A$7.2m

FY2016FY2026

Income statement

Fiscal years

FY2026FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue———A$2.5mA$69,731—————
Gross profit———A$2.5mA$69,731—————
Research and development———A$3.4mA$1.6mA$1.8mA$6.0mA$3.7mA$3.5mA$1.1m
Operating income−A$2.1m−A$2.0m−A$2.5m−A$6.9m−A$8.1m−A$9.6m−A$8.3m−A$7.6m−A$11.4m−A$3.3m
Net income−A$3.3m−A$1.9m−A$2.5m−A$7.1m−A$6.8m−A$8.5m−A$5.4m−A$6.5m−A$10.0m−A$3.2m
Diluted earnings per share-0.01-0.00-0.00-0.01-0.01-0.01-0.01-0.01-0.02-0.00

Balance sheet

At each fiscal year end

FY2026FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsA$7.5mA$2.2mA$3.4mA$5.8mA$9.4mA$8.9mA$9.4mA$6.5mA$12.0mA$16.3m
Cash and short-term investments———A$2.4mA$6.6mA$5.8mA$5.5mA$3.4mA$8.6mA$13.7m
Total liabilitiesA$335,436A$218,929A$132,524A$5.1mA$1.8mA$1.9mA$1.7mA$910,359A$638,670A$244,936
Debt———A$38,921A$190,998A$328,891————
Shareholders' equityA$7.2mA$1.9mA$3.3mA$689,561A$7.6mA$7.0mA$7.7mA$5.5mA$11.3mA$16.0m
Shares outstanding641m641m641m641m641m685m685m685m659m655m

Cash flow

Fiscal years

FY2026FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations———−A$7.1m——————
Capital spending−A$262,986—−A$80,585−A$161,139−A$46,130−A$9,750−A$36,131———
Free cash flow———−A$7.3m——————

Latest quarters

By quarter end

Jun 2022Dec 2021Jun 2021Dec 2020Sept 2020Jun 2020Mar 2020Dec 2019
RevenueA$2.4mA$82,600A$27,600A$58,900————
Operating income−A$3.3m−A$3.6m−A$3.6m−A$3.1m−A$2.4m−A$2.4m−A$2.4m−A$2.4m
Net income−A$3.5m−A$3.6m−A$3.6m−A$3.1m−A$2.1m−A$2.1m−A$2.1m−A$2.1m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assetsA$5.8mA$6.2mA$9.4mA$7.4m—A$8.9m——
Cash and short-term investmentsA$2.4mA$3.4mA$6.6mA$4.2m—A$5.8m——
DebtA$38,921—A$152,077A$110,200—A$137,891——
Shareholders' equityA$689,561A$4.1mA$7.6mA$5.5m—A$7.0m——

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-32.5%-26.0%12.4%
Net income-22.7%-17.3%21.0%

Valuation history

At each fiscal year end

FY2026FY2024FY2023FY2022FY2021
Price to earnings-2.9-2.2-4.3-3.2-8.2
Price to sales———8.9—

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1-to-1 reverse split · 29 May 2015
  • 1-to-1 reverse split · 9 Nov 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.